Breast cancer risk of hormonal contraception: Counselling considering new evidence
-
Published:2019-05
Issue:
Volume:137
Page:123-130
-
ISSN:1040-8428
-
Container-title:Critical Reviews in Oncology/Hematology
-
language:en
-
Short-container-title:Critical Reviews in Oncology/Hematology
Author:
Del Pup Lino,
Codacci-Pisanelli GiovanniORCID,
Peccatori Fedro
Subject
Oncology,Hematology
Reference42 articles.
1. Use of the levonorgestrel-releasing intrauterine system and breast cancer;Backman;Obstet. Gynecol.,2005
2. Oral contraceptives and menopausal hormone therapy: relative and attributable risks of cardiovascular disease, cancer, and other health outcomes;Bassuk;Ann. Epidemiol.,2015
3. Oral contraceptives and breast cancer risk overall and by molecular subtype among young women;Beaber;Cancer Epidemiol. Biomark. Prev.,2014
4. Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS collaborating group;Brohet;J. Clin. Oncol.,2007
5. Progestin-only and combined oral contraceptives and receptor-defined premenopausal breast cancer risk: the Norwegian Women and Cancer study;Busund;Int. J. Cancer,2018
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献